IMMUNOTECH-B (06978) issued 103 million shares for the rights issue offering.
Yongtai Biological-B (06978) announced that on November 13, 2025, a rights issue was conducted whereby shareholders were entitled to subscribe for one share for every five shares held.
IMMUNOTECH-B (06978) announced that on November 13, 2025, the company will issue 103 million new shares for every five existing shares held as part of a rights issue scheme.
Related Articles
CHINA XLX FERT(01866): Gan Meixia appointed as Joint Company Secretary, Authorized Representative, and Legal Process Representative.
Dongrui Food Group (001201.SZ) has obtained additional quotas for exporting live large pigs to Hong Kong in the year 2025.
Selected A-share Announcements | Semiconductor Manufacturing International Corporation (688981.SH) Third Quarter Report Released! Net profit exceeds 1.5 billion yuan in Q3.
CHINA XLX FERT(01866): Gan Meixia appointed as Joint Company Secretary, Authorized Representative, and Legal Process Representative.
Dongrui Food Group (001201.SZ) has obtained additional quotas for exporting live large pigs to Hong Kong in the year 2025.
Selected A-share Announcements | Semiconductor Manufacturing International Corporation (688981.SH) Third Quarter Report Released! Net profit exceeds 1.5 billion yuan in Q3.
RECOMMEND
Energy Storage Industry Set To Ride the AI Tailwind; UBS: Global Demand May Surge 40% Next Year
13/11/2025
Double Eleven’s Cooling To A Historic Low? A Necessary Step Toward E‑commerce Maturity
13/11/2025
On The Eve of L3 Mass Commercialization: How Autonomous Driving Will Reconfigure a Trillion‑Yuan Service Market
13/11/2025
